Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-23

Clinical Trial Update: Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus.

View source ↗

Summary

A completed clinical trial evaluated levels of thrombospondin-1 and pigment epithelium-derived factor in patients with diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: MidAtlantic Retina | Conditions: Diabetes, Diabetes Mellitus | Status: COMPLETED